Open access
Oct 2026
Biapenem–fosfomycin shows enhanced in vitro activity compared with meropenem–fosfomycin against NDM-producing Enterobacterales
ABSTRACT Treatment options for New Delhi metallo-β-lactamase-producing Enterobacterales (NDME) remain limited, and the clinical relevance of fosfomycin–carbapenem combinations has not been fully established. We evaluated whether biapenem–fosfomycin provides greater in vitro activity than meropenem–fosfomycin. A total o...
Takashi Okanda, Daishu Fukushima, Natsuki Yumura et al.
· Microbiology spectrum · 0 citations